Target intelligence / Profile preview

Poliovirus receptor-related 1 (Nectin-1)

Target
Nectin-1
Molecular classification
Immunoglobulin superfamily cell adhesion molecule, Cell adhesion molecule (CAM), Receptor
01

Overview

Poliovirus receptor-related 1 (Nectin-1, CD111, PVRL1) is a membrane protein and a member of the immunoglobulin superfamily of cell adhesion molecules, characterized by three extracellular immunoglobulin-like domains, a single transmembrane segment, and a cytoplasmic tail that binds the scaffolding protein afadin[6][2][7][8]. Nectin-1 localizes to adherens junctions in epithelial tissues and is crucial for the formation and maintenance of synapses in neural tissue[6][4][2][3]. It mediates both homophilic (Nectin-1/Nectin-1) and heterophilic (Nectin-1/Nectin-3) interactions, impacting tissue organization and signaling. Nectin-1 is the major entry receptor for Herpes simplex viruses and related alphaherpesviruses, as binding of viral glycoprotein D to Nectin-1 is essential for infection initiation[1][7][5]. Disruption or genetic variants in Nectin-1 are implicated in neurological and developmental disorders as well as serving as a potential cancer cell adhesion modulator. There are currently no approved drugs targeting Nectin-1 directly for therapeutic purposes.

Other names
Nectin-1CD111PVRL1Herpesvirus entry mediator C (HVEC)
02

Mechanism of action

Acts as a viral entry receptor: Herpes simplex virus glycoprotein D binds Nectin-1, facilitating viral entry into host cells[1][6][7]

03

Biological functions

Cell–cell adhesionFormation of adherens and synaptic junctionsImmune modulationViral entry receptor
04

Disease associations

Infection (notably as an entry receptor for several herpesviruses, including Herpes simplex virus types 1 and 2)Potential roles in cancer (through modulation of adhesion and signaling pathways)Neurological development disorders (due to roles in synaptic formation)Other (implicated in certain congenital syndromes)
05

Safety considerations

As a viral receptor, viral entry may exacerbate viral pathogenesis if targeted or modulatedBlocking Nectin-1 could potentially disrupt normal cell–cell adhesion and neural synaptic organizationPotential effects on immune modulation due to its role in immune cell interactions[2][3][4]

Beyond the preview

Go deeper on Poliovirus receptor-related 1 (Nectin-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poliovirus receptor-related 1 (Nectin-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call